Emily Schwarz
Immunology and Microbiology · The Ohio State University
Publications
157
Citations
5,750
Est. group size
~18
Recurring co-author estimate
Active years
60
Publishing since 1967
Emily Schwarz's available bibliographic record centers on a single 2024 study analyzing changes in plasma cytokine levels in response to IL-12 therapy across three clinical trials, with the listed publications largely being supplementary figures, tables, and data files associated with that study. This suggests work in immunology related to cytokine signaling and immunotherapy, particularly the interleukin-12 (IL-12) pathway, which is involved in immune cell activation and is studied in the context of cancer treatment.
Publication output was minimal or absent through 2020, then rose sharply from 2021 onward, peaking in 2024, indicating a recent and rapidly growing surge in output tied largely to one clinical study and its associated supplementary materials.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Figure S2 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- Data from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- FIGURE 4 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- FIGURE 1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- FIGURE 5 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- TABLE 3 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- TABLE 1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- TABLE 3 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- TABLE 2 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- Figure S2 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- FIGURE 3 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- TABLE 1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- FIGURE 3 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- Figure S1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- Figure S1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
2024
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Regular and Young Investigator Award Abstracts×2
- Cancer Research×2
- Clinical Cancer Research×1
- Cancer Immunology Research×1
- Gabriella Lapurga
Immunology and Microbiology · The Ohio State University
- Sara Zelinskas
Immunology and Microbiology · The Ohio State University
- Jianying Li
Immunology and Microbiology · The Ohio State University
- Andrew Stiff
Immunology and Microbiology · The Ohio State University
- Carter Allen
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile